Back
Probe Gold, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
65
PROBF
Probe Gold, Inc.
Last Price:
$2.65
Seasonality Move:
24.14%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$56.88
Seasonality Move:
16.15%
Buy
65
Probe Gold, Inc. (PROBF)
is a Buy
Is Probe Gold, Inc. a Buy, Sell or Hold?
-
The current Probe Gold, Inc. [PROBF] share price is $2.66. The Score for PROBF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
PROBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.97. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PROBF Stock Price Chart
What is Probe Gold, Inc.'s stock price today?
-
The Probe Gold, Inc. share price today is $2.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
PROBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 65.89 | Buy |
| Chaikin Money Flow: | -95852 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 48.84 | Sell |
| Chaikin Money Flow: | -466021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.56 - 56.88) | Buy |
| Bollinger Bands (100): | (52.61 - 65.53) | Sell |
PROBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.66 | Buy |
| 20-day SMA: | 2.62 | Buy |
| 50-day SMA: | 2.4 | Buy |
| 200-day SMA: | 1.84 | Buy |
| 8-day EMA: | 2.65 | Buy |
| 20-day EMA: | 2.61 | Buy |
| 50-day EMA: | 2.41 | Buy |
| 200-day EMA: | 1.41 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.98 | Sell |
| 20-day SMA: | 54.45 | Buy |
| 50-day SMA: | 60.1 | Sell |
| 200-day SMA: | 50.92 | Buy |
| 8-day EMA: | 56.41 | Sell |
| 20-day EMA: | 56 | Sell |
| 50-day EMA: | 56.51 | Sell |
| 200-day EMA: | 37.03 | Buy |
Probe Gold, Inc. Earnings Growth & PROBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Probe Gold, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||